• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
MRSA: why have we got it and can we do anything about it?耐甲氧西林金黄色葡萄球菌(MRSA):我们为什么会感染它,我们能做些什么?
Eye (Lond). 2012 Feb;26(2):218-21. doi: 10.1038/eye.2011.314. Epub 2011 Dec 2.
2
Prevention of meticillin-resistant Staphylococcus aureus bloodstream infections in European hospitals: moving beyond policies.欧洲医院耐甲氧西林金黄色葡萄球菌血流感染的预防:超越政策层面
J Hosp Infect. 2014 Aug;87(4):203-11. doi: 10.1016/j.jhin.2014.05.003. Epub 2014 Jun 5.
3
Responsibility for managing healthcare-associated infections: where does the buck stop?负责管理医疗机构相关感染:责任止于何处?
J Hosp Infect. 2009 Dec;73(4):414-7. doi: 10.1016/j.jhin.2009.06.027. Epub 2009 Sep 17.
4
Long-term control of endemic hospital-wide methicillin-resistant Staphylococcus aureus (MRSA): the impact of targeted active surveillance for MRSA in patients and healthcare workers.长期控制地方性医院耐甲氧西林金黄色葡萄球菌(MRSA):针对患者和医护人员进行目标性主动监测对 MRSA 的影响。
Infect Control Hosp Epidemiol. 2010 Aug;31(8):786-95. doi: 10.1086/654003.
5
Compliance of hospital staff with guidelines for the active surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and its impact on rates of nosocomial MRSA bacteremia.医院工作人员对耐甲氧西林金黄色葡萄球菌(MRSA)主动监测指南的依从性及其对医院获得性MRSA菌血症发生率的影响。
Isr Med Assoc J. 2011 Dec;13(12):740-4.
6
Significant reduction of endemic MRSA acquisition and infection in cardiothoracic patients by means of an enhanced targeted infection control programme.通过强化目标性感染控制方案,显著降低心胸外科患者中耐甲氧西林金黄色葡萄球菌(MRSA)的获得率和感染率。
J Hosp Infect. 2005 Jun;60(2):104-10. doi: 10.1016/j.jhin.2004.11.020.
7
Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study.评价英格兰和威尔士全国“清洁双手”运动通过改善手部卫生减少金黄色葡萄球菌菌血症和艰难梭菌感染的效果:四年前瞻性生态间断时间序列研究。
BMJ. 2012 May 3;344:e3005. doi: 10.1136/bmj.e3005.
8
Infection control link nurse program: an interdisciplinary approach in targeting health care-acquired infection.感染控制联络护士项目:一种针对医疗保健相关感染的跨学科方法。
Am J Infect Control. 2014 Apr;42(4):353-9. doi: 10.1016/j.ajic.2013.10.007. Epub 2014 Feb 16.
9
Waves of trouble: MRSA strain dynamics and assessment of the impact of infection control.一波又一波的麻烦:耐甲氧西林金黄色葡萄球菌(MRSA)菌株动态及其对感染控制效果的评估。
J Antimicrob Chemother. 2011 Dec;66(12):2685-8. doi: 10.1093/jac/dkr392. Epub 2011 Sep 21.
10
Trends in sources of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia: data from the national mandatory surveillance of MRSA bacteraemia in England, 2006-2009.耐甲氧西林金黄色葡萄球菌(MRSA)菌血症的来源趋势:2006-2009 年英格兰全国性耐甲氧西林金黄色葡萄球菌菌血症强制性监测数据。
J Hosp Infect. 2011 Nov;79(3):211-7. doi: 10.1016/j.jhin.2011.05.013. Epub 2011 Jul 20.

引用本文的文献

1
Agents Targeting the Bacterial Cell Wall as Tools to Combat Gram-Positive Pathogens.靶向细菌细胞壁的药物:对抗革兰氏阳性病原体的工具。
Molecules. 2024 Aug 27;29(17):4065. doi: 10.3390/molecules29174065.
2
Chromogenic media for MRSA diagnostics.用于耐甲氧西林金黄色葡萄球菌诊断的显色培养基。
Mol Biol Rep. 2016 Nov;43(11):1205-1212. doi: 10.1007/s11033-016-4062-3. Epub 2016 Aug 25.
3
Methicillin-resistant Staphylococcus aureus (MRSA) in an Austrian urological department: 10 years experience covering 95.161 patients.奥地利泌尿科病房耐甲氧西林金黄色葡萄球菌(MRSA):覆盖 95161 名患者的 10 年经验。
World J Urol. 2013 Jun;31(3):559-63. doi: 10.1007/s00345-012-0920-3. Epub 2012 Aug 5.

本文引用的文献

1
Responsibility for managing healthcare-associated infections: where does the buck stop?负责管理医疗机构相关感染:责任止于何处?
J Hosp Infect. 2009 Dec;73(4):414-7. doi: 10.1016/j.jhin.2009.06.027. Epub 2009 Sep 17.

耐甲氧西林金黄色葡萄球菌(MRSA):我们为什么会感染它,我们能做些什么?

MRSA: why have we got it and can we do anything about it?

机构信息

Department of Medical Microbiology, Cardiff University, Chepstow, UK.

出版信息

Eye (Lond). 2012 Feb;26(2):218-21. doi: 10.1038/eye.2011.314. Epub 2011 Dec 2.

DOI:10.1038/eye.2011.314
PMID:22134591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3272211/
Abstract

MRSA, first identified in 1960, became a major cause of healthcare-associated infection with the emergence of epidemic strains EMRSA 15 and 16 in the 1990 s. MRSA bacteraemia surveillance in England showed a peak of 7700 in 2003-2004. A target was set to halve MRSA bacteraemias by 2008 backed by a central improvement programme for infection prevention and control. Healthcare-associated infection is a patient safety issue with joint responsibility between: clinicians responsible for patient care; managers responsible for the organisation of services; and the government/Department of Health responsible for national strategy, prioritisation and performance management, together with introducing a statutory Code of Practice. By 2011, the number of MRSA bacteraemias had reduced by 80% to 1481. The key drivers of improvement were management responsibility, enhanced surveillance, adherence to clinical protocols and care bundles for invasive procedures, hand hygiene and environmental cleaning, and improved isolation procedures and antibiotic stewardship. The target has been translated into an ongoing MRSA objective, and further control of MRSA is supported by a screening programme aimed at all relevant hospital admissions. Sustaining the reduction will depend upon joint responsibility between management maintaining compliance assurance with policies and individual clinicians keeping it as a priority in patient safety.

摘要

耐甲氧西林金黄色葡萄球菌(MRSA)于 1960 年首次被发现,随着 20 世纪 90 年代流行株 EMRSA-15 和 EMRSA-16 的出现,成为了医疗保健相关感染的主要原因。英格兰的耐甲氧西林金黄色葡萄球菌菌血症监测显示,2003-2004 年达到了 7700 例的峰值。在中央感染预防和控制改善计划的支持下,设定了到 2008 年将耐甲氧西林金黄色葡萄球菌菌血症减少一半的目标。医疗保健相关感染是一个患者安全问题,涉及以下方面的共同责任:负责患者护理的临床医生;负责服务组织的管理人员;以及负责国家战略、优先事项和绩效管理的政府/卫生部,同时引入法定的实践准则。到 2011 年,耐甲氧西林金黄色葡萄球菌菌血症的数量减少了 80%,降至 1481 例。改善的关键驱动因素是管理责任、加强监测、遵守侵入性程序的临床方案和护理包、手卫生和环境清洁,以及改进的隔离程序和抗生素管理。这一目标已经转化为一个正在进行的耐甲氧西林金黄色葡萄球菌目标,通过一项针对所有相关住院患者的筛查计划,进一步控制耐甲氧西林金黄色葡萄球菌。维持这种减少将取决于管理层之间的共同责任,确保政策的合规性,以及个体临床医生将其作为患者安全的优先事项。